We demonstrate the effectiveness of readministering cetuximab as a
salvage chemotherapeutic agent after nivolumab administration to a
patient with a recurrence of cervical lymph node metastasis after tongue
cancer surgery. We can infer that the immunostimulatory effect of
nivolumab and reactivation of cetuximab enhance the antitumor effect of
the therapy.